{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:13:16Z","timestamp":1793812396153,"version":"4.6.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.autrev.2021.102780","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T10:14:34Z","timestamp":1613902474000},"page":"102780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Neuropsychiatric involvement in systemic lupus erythematosus: A review"],"prefix":"10.1016","volume":"20","author":[{"given":"Irene","family":"Carri\u00f3n-Barber\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Carlos","family":"Salman-Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"V\u00edlchez-Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102780_bb0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.berh.2010.10.006","article-title":"Systemic Lupus erythematosus","volume":"24","author":"Oneil","year":"2010","journal-title":"Best Pr Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2016.06.013","article-title":"The diagnosis and clinical management of the neuropsychiatric manifestations of lupus","volume":"74","author":"Govoni","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102780_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new american college of rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0030","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","author":"Bortoluzzi","year":"2014","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2021.102780_bb0035","first-page":"103","article-title":"Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?","volume":"12","author":"Monov","year":"2008","journal-title":"Hippokratia"},{"key":"10.1016\/j.autrev.2021.102780_bb0040","first-page":"2156","article-title":"Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance","volume":"31","author":"Hanly","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0045","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.autrev.2020.102592","article-title":"The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: a narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines","volume":"19","author":"Deijns","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/key354","article-title":"Autoantibodies in neuropsychiatric lupus: still looking","volume":"58","author":"Bhattacharyya","year":"2019","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0055","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000359","article-title":"Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Hirohata","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102780_bb0070","first-page":"908","article-title":"Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus","volume":"58","author":"Pr\u00f6bstel","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2021.102780_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2018.12.004","article-title":"Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus","volume":"18","author":"Duarte-Delgado","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold?","volume":"5","author":"Vivaldo","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0085","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of Neuropsychiatric Systemic Lupus Erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2021.102780_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-019-1012-1","article-title":"Neurological complications in patients with systemic Lupus erythematosus","volume":"19","author":"Shaban","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.autrev.2021.102780_bb0100","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.38106","article-title":"Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study","volume":"65","author":"Hanly","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0105","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/brain\/awh146","article-title":"A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth","volume":"127","author":"Mitsikostas","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2021.102780_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1191\/0961203303lu506oa","article-title":"Headache and systemic lupus erythematosus","volume":"12","author":"Cuadrado","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2021.102780_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31138\/mjr.30.1.7","article-title":"Cerebrovascular events in systemic lupus erythematosus: diagnosis and management","volume":"30","author":"Nikolopoulos","year":"2019","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0125","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.autrev.2020.102693","article-title":"Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: a multicenter study with 1519 patients","volume":"19","author":"Islab\u00e3o","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0961203318816819","article-title":"Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort","volume":"28","author":"Magro-Checa","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0135","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102780_bb0150","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.autrev.2018.04.009","article-title":"Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis","volume":"17","author":"Dufrost","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.thromres.2004.06.039","article-title":"Libman-sacks endocarditis associated with antiphospholipid syndrome and infection","volume":"114","author":"Blank","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0160","article-title":"Multiple embolic strokes as a result of Libman-Sacks endocarditis associated with lupus and secondary antiphospholipid antibody syndrome: A case report","volume":"2","author":"Arnautovic","year":"2018","journal-title":"Eur Hear J - Case Reports"},{"key":"10.1016\/j.autrev.2021.102780_bb0165","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jcmg.2013.04.012","article-title":"Libman-sacks endocarditis and embolic cerebrovascular disease","volume":"6","author":"Roldan","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.autrev.2021.102780_bb0170","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.2004.026542","article-title":"Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus","volume":"64","author":"Rowshani","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0175","first-page":"75","article-title":"CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography","volume":"20","author":"Pomper","year":"1999","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2021.102780_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-010-0102-6","article-title":"The role of imaging in the diagnosis of central nervous system vasculitis","volume":"10","author":"Gomes","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.autrev.2021.102780_bb0185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/0961203317694259","article-title":"Central nervous system vasculitis in systemic lupus erythematosus: a case series report in a tertiary referral Centre","volume":"26","author":"Rodrigues","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0190","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.1780391213","article-title":"Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"39","author":"Kozora","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12026-015-8713-6","article-title":"Integrative neuroscience approach to neuropsychiatric lupus","volume":"63","author":"Huerta","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2019.00052","article-title":"MG. Lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.23098","article-title":"General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus","volume":"57","author":"Tomietto","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semarthrit.2011.02.005","article-title":"Memantine in systemic Lupus erythematosus: a randomized, double-blind placebo-controlled trial","volume":"41","author":"Petri","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5698\/1535-7597-13.2.62","article-title":"Epilepsy associated with systemic autoimmune disorders","volume":"13","author":"Devinsky","year":"2013","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.autrev.2021.102780_bb0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0225","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1177\/0961203316636473","article-title":"Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations","volume":"25","author":"Kampylafka","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0235","first-page":"25","article-title":"Seizures in patients with systemic lupus erythematosus","volume":"2","author":"Wang","year":"1997","journal-title":"Neurol J Southeast Asia"},{"key":"10.1016\/j.autrev.2021.102780_bb0240","first-page":"1495","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"65","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0245","series-title":"Textbook of pediatric rheumatology","first-page":"610","article-title":"Textbook of pediatric rheumatology","author":"Cassidy","year":"1995"},{"key":"10.1016\/j.autrev.2021.102780_bb0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2021.102780_bb0255","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"140","author":"Baizabal-Carvallo","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.autrev.2021.102780_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/RHU.0b013e31820e7c8d","article-title":"Chorea in systemic lupus erythematosus","volume":"17","author":"Baizabal-Carvallo","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0265","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","article-title":"Movement disorders in paraneoplastic and autoimmune disease","volume":"24","author":"Panzer","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0270","first-page":"2010","article-title":"Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-\u03b1, IgG index, and Q-albumin","volume":"34","author":"Katsumata","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0275","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102780_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13075-014-0450-z","article-title":"Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102780_bb0285","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/14397595.2016.1193966","article-title":"Brain MRI in patients with acute confusional state of diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"27","author":"Abe","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2190\/P2T8-Y12E-ANKM-8MWF","article-title":"Risperidone in the treatment of acute confusional state (delirium) due to neuropsychiatric lupus erythematosus: case report","volume":"33","author":"Nishimura","year":"2003","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005792-199711000-00006","article-title":"Cytotoxic therapy in systemic lupus erythematosus: experience from a single center","volume":"76","author":"Rahman","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2021.102780_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","article-title":"The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Neuwelt","year":"2003","journal-title":"Ther Apher"},{"key":"10.1016\/j.autrev.2021.102780_bb0305","article-title":"Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors","volume":"97","author":"Figueiredo-Braga","year":"2018","journal-title":"Med (United States)"},{"key":"10.1016\/j.autrev.2021.102780_bb0310","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"67","author":"Hanly","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0315","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","article-title":"Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease","volume":"47","author":"Pego-reigosa","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102780_bb0320","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.61.1.104","article-title":"Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus","volume":"61","author":"Chau","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102780_bb0325","first-page":"644","article-title":"Central nervous system disease in systemic lupus erythematosus","volume":"58","author":"Sergent","year":"1975","journal-title":"Therapy and Prognosis Am J Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0330","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"51","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0335","first-page":"111","article-title":"Antibodies associated with neuropsychiatric lupus: pathophysiological role, prevalence and diagnostic usefulness","volume":"26","author":"Mar\u00edn","year":"2019","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0340","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0345","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y","article-title":"Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus","volume":"41","author":"Isshi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(03)00135-9","article-title":"Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study","volume":"115","author":"Mok","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000186504","article-title":"Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus","volume":"61","author":"Baizabal-Carvallo","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0360","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.1978.03280380062020","article-title":"Ibuprofen-induced meningitis in systemic Lupus erythematosus","volume":"239","author":"Widener","year":"1978","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.autrev.2021.102780_bb0365","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.1978.03290060031005","article-title":"Azathioprine-induced meningitis in systemic Lupus erythematosus","volume":"240","author":"Sergent","year":"1978","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.autrev.2021.102780_bb0370","doi-asserted-by":"crossref","DOI":"10.4081\/reumatismo.2017.1007","article-title":"Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series","author":"Chessa","year":"2017","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2021.102780_bb0375","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.01.011","article-title":"Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis","volume":"16","author":"Piga","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102780_bb0380","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2021.102780_bb0385","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.68.2.170","article-title":"Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study","volume":"68","author":"Rovaris","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2021.102780_bb0390","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.58.8_suppl_4.S23","article-title":"MRI in the diagnosis and management of multiple sclerosis","volume":"58","author":"Arnold","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102780_bb0395","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0400","first-page":"290","article-title":"Demyelination in rheumatic diseases","volume":"77","author":"Theodoridou","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.autrev.2021.102780_bb0405","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.40356","article-title":"Understanding the antibody repertoire in neuropsychiatric systemic Lupus erythematosus and Neuromyelitis Optica Spectrum disorder: do they share common targets?","volume":"70","author":"Mader","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.berh.2013.07.010","article-title":"Demyelinating disease in SLE: is it multiple sclerosis or lupus?","volume":"27","author":"Magro Checa","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0425","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0430","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3174\/ajnr.A3645","article-title":"Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome","volume":"35","author":"Kaichi","year":"2014","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2021.102780_bb0435","article-title":"Transverse myelitis in systemic lupus erythematosus in Thai patients","volume":"13","author":"Feijoo","year":"2007","journal-title":"Reum Clin"},{"key":"10.1016\/j.autrev.2021.102780_bb0440","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic Lupus erythematosus or Lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D\u2019Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0445","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archneur.1979.00500460077012","article-title":"Devic\u2019s syndrome and systemic Lupus erythematosus: a case report with necropsy","volume":"36","author":"Kinney","year":"1979","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0455","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2007-1019132","article-title":"An approach to the diagnosis of acute transverse myelitis","volume":"28","author":"Jacob","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0460","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jocn.2017.06.003","article-title":"Myelitis in systemic lupus erythematosus","volume":"44","author":"Li","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2021.102780_bb0470","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/540738","article-title":"Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic Lupus erythematosus: a single-Centre experience in China","author":"Wang","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0475","doi-asserted-by":"crossref","first-page":"104372","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104372","article-title":"Cerebral venous sinus thrombosis as a rare complication of systemic Lupus erythematosus: subgroup analysis of the VENOST study","volume":"28","author":"Duman","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0480","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3346\/jkms.2001.16.3.351","article-title":"Systemic Lupus erythematosus complicated with cerebral venous sinus thrombosis\u202f: a report of two cases","volume":"16","author":"Lee","year":"2001","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2021.102780_bb0485","first-page":"74","article-title":"Diagnosis and management of posterior reversible encephalopathy syndrome in systemic Lupus erythematosus. Case report","volume":"26","author":"Fuseau Herrera","year":"2019","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0490","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jnnp-2014-310145","article-title":"Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study","volume":"87","author":"Merayo-Chalico","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2021.102780_bb0495","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13760-017-0750-6","article-title":"Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome","volume":"117","author":"Della","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.autrev.2021.102780_bb0500","first-page":"67","article-title":"Neuroimagen en el s\u00edndrome de encefalopat\u00eda reversible posterior","volume":"5","author":"Cuellar","year":"2006","journal-title":"An Radiol M\u00e9xico"},{"key":"10.1016\/j.autrev.2021.102780_bb0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0037-1600517","article-title":"Posterior reversible encephalopathy: an epileptic syndrome?","volume":"48","author":"Hartmann","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.autrev.2021.102780_bb0510","doi-asserted-by":"crossref","DOI":"10.1177\/0885066610393634","article-title":"Posterior reversible encephalopathy syndrome","author":"Staykov","year":"2012","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0515","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3899\/jrheum.101308","article-title":"Posterior reversible encephalopathy syndrome in systemic lupus erythematosus","volume":"38","author":"Varaprasad","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0520","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2169\/internalmedicine.47.0741","article-title":"Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis","volume":"47","author":"Zhang","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0525","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/RHU.0b013e3182a21ffd","article-title":"Posterior reversible encephalopathy syndrome in systemic lupus erythematosus","volume":"19","author":"Gatla","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0530","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/1756-185X.12337","article-title":"Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review","volume":"17","author":"Man","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0535","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s100670050069","article-title":"Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis","volume":"18","author":"Giorgi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0540","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1986.01050160120026","article-title":"Optic neuropathy in systemic Lupus erythematosus","volume":"104","author":"Jabs","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102780_bb0545","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12659\/AJCR.912875","article-title":"Acute unilateral vision loss due to optic neuropathy in a patient with systemic lupus erythematosus","volume":"20","author":"Heckman","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.autrev.2021.102780_bb0550","article-title":"Systemic Lupus erythematosus presenting as optic neuropathy: a case report","volume":"11","author":"Zahid","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2021.102780_bb0555","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4103\/0301-4738.109535","article-title":"Nonarteritic anterior ischemic optic neuropathy as the presenting manifestation of primary antiphospholipid syndrome","volume":"62","author":"Tugcu","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102780_bb0560","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases","volume":"60","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0565","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/TCRM.S167109","article-title":"A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus","volume":"14","author":"Ishikawa","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2021.102780_bb0570","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/373579","article-title":"Human polyomavirus reactivation: disease pathogenesis and treatment approaches","author":"De Gascun","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2021.102780_bb0575","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1086\/318120","article-title":"Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases","volume":"31","author":"Haider","year":"2000","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.autrev.2021.102780_bb0580","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/517060","article-title":"Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside","volume":"26","author":"Smith","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2021.102780_bb0585","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0961203311435267","article-title":"Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience","volume":"21","author":"Kim","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0590","first-page":"55","article-title":"Whence pseudotumor cerebri?","volume":"5","author":"Smith","year":"1985","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.autrev.2021.102780_bb0595","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/08820530801888188","article-title":"Intracranial hypertension in systemic lupus erythematosus","volume":"23","author":"Dave","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102780_bb0600","article-title":"Peripheral neuropathies due to systemic lupus erythematosus in China","volume":"94","author":"Xianbin","year":"2015","journal-title":"Med (United States)"},{"key":"10.1016\/j.autrev.2021.102780_bb0605","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2011.04.001","article-title":"Peripheral neuropathy in patients with systemic Lupus erythematosus","volume":"41","author":"Florica","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0610","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.38302","article-title":"Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period","volume":"66","author":"Oomatia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0615","first-page":"146","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome","volume":"37","author":"Bortoluzzi","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0620","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.2169\/internalmedicine.1106-18","article-title":"Monocular oculomotor nerve disorder manifesting as cranial neuropathy in systemic lupus erythematosus","volume":"57","author":"Nakamagoe","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2021.102780_bb0625","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102780_bb0630","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12659\/AJCR.903541","article-title":"Chronic inflammatory demyelinating polyneuropathy (CIDP): An uncommon manifestation of systemic lupus erythematosus (SLE)","volume":"18","author":"Abraham","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.autrev.2021.102780_bb0635","first-page":"617","article-title":"Report from an ad hoc Subcommittee of the American Academy of neurology AIDS task force","volume":"42","author":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102780_bb0640","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00296-005-0093-0","article-title":"Autonomic dysfunction in systemic lupus erythematosus","volume":"26","author":"Shalimar","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.102780_bb0645","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2021.102780_bb0650","doi-asserted-by":"crossref","DOI":"10.4103\/2277-9175.183662","article-title":"The autonomic dysfunction in patients with lupus disease: an electrophysiological study","volume":"5","author":"Haghighat","year":"2016","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.autrev.2021.102780_bb0655","first-page":"1092","article-title":"Autonomic dysfunction in patients with systemic lupus erythematosus","volume":"25","author":"Gamez-Nava","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102780_bb0660","doi-asserted-by":"crossref","DOI":"10.1177\/096120339600500114","article-title":"Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide","author":"Martinez-Taboada","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102780_bb0665","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-017-8519-7","article-title":"Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study","author":"Rivi\u00e8re","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0670","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2021.102780_bb0675","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000441-200601000-00004","article-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study","volume":"331","author":"Sthoeger","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2021.102780_bb0680","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/ijn.IJN_12_18","article-title":"Systemic lupus erythematosus and myasthenia gravis: a rare association","volume":"29","author":"Nagarajan","year":"2019","journal-title":"Indian J Nephrol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:10Z","timestamp":1761600070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":136,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1568997221000434"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102780","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric involvement in systemic lupus erythematosus: A review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102780"}}